Geron (GERN) announced the appointment of Harout Semerjian as president and CEO and a member of the board of directors, effective tomorrow. Semerjian will succeed Dawn Carter Bir, who has served as interim president and CEO since March 2025. Bir will continue in her role on Geron’s board of directors, where she will contribute her insight and strategic counsel.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GERN:
- Geron reports Q2 EPS (2c), consensus (3c)
- GERN Earnings this Week: How Will it Perform?
- Cautiously Optimistic: Geron’s Strategic Changes and Growth Prospects Support Buy Rating
- Geron resumed with a Sell at Goldman Sachs
- Geron Corp’s Rytelo Faces Market Challenges and Declining Physician Adoption, Supporting Sell Rating